| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000019555 |
| Receipt No. | R000022613 |
| Official scientific title of the study | Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation |
| Date of disclosure of the study information | 2015/10/30 |
| Last modified on | 2017/05/19 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation | |
| Title of the study (Brief title) | Efficacy of Automated Ablation Annotation Algorithm(Visitag) in Reducing Re-conduction of Isolated Pulmonary Vein and Recurrence after Catheter Ablation for Atrial Fibrillation | |
| Region |
|
|
| Condition | ||
| Condition | Atrial Fibrillation | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is to compare automatic annotation system with manual tag during CPVI using CARTO system and contact force catheter. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | recurrence of atrial fibrillation(1 year) |
| Key secondary outcomes | Spontaneous PV reconnection; Dormant conduction by ATP; duration of energy application ; total energy; procedure time; and complications associated with catheter ablation |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | RF Ablation using CARTO system. Manual collection of RF ablation points by assistant. | |
| Interventions/Control_2 | RF ablation was guided by an automated algorithm with predefined criteria of catheter stability range of motion; 1.5mm ,catheter stability duration ;5 seconds, and force over time (contact force;5g, time;25%). When this condition is satisfied, new tag appears. Tag size was 3mm and we intended to move catheter to next position to appear the new tag where was overlapped with the former tag. When force time integral (FTI) of the tag becomes 100-150gs, the color of tag changed from white to red and we moved catheter to the next position. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients undergoing initial ablation for paroxysmal or persistent (duration < 5 year) atrial fibrillation | |||
| Key exclusion criteria | Patients with sustained atrial fibrillation episode 5 years or greater;
Patients with left atrial size 50 mm or larger or left atrial volume 200ml or larger; Patients with valvular atrial fibrillation and a history of cardiac surgery; Patients age is < 20 years or 80 years or greater; Dialysis patients; Patients with heart failure (LVEF < 30% or NYHA class III or IV); Patients taking antiarrhythmic drugs before procedure; or Patients considered unsuitable for this study |
|||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Koichi Inoue |
| Organization | Sakurabashi Watanabe Hospital |
| Division name | Cardiovascular center |
| Address | 2-4-32 Umeda, Kita, Osaka, Japan |
| TEL | 06-6341-8655 |
| inoueko1@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Nobuaki Tanaka |
| Organization | Sakurabashi Watanabe Hospital |
| Division name | Cardiovascular center |
| Address | 2-4-32 Umeda, Kita, Osaka, Japan |
| TEL | 06-6341-8655 |
| Homepage URL | |
| nob-t@tj9.so-net.ne.jp | |
| Sponsor | |
| Institute | Sakurabashi Watanabe Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022613 |